(Q27140121)
Statements
C1C(C(C(C(C1[NH3+])OC2C(C(C(C(O2)CO)O)[NH3+])O)O)OC3C(C(C(C(O3)CO)O)O)[NH3+])[NH3+]
1 reference
kanamycin C tetracation (English)
7 October 2016
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)[NH3+])[NH3+]
1 reference
kanamycin C tetracation (English)
7 October 2016
Identifiers
1 reference
kanamycin C tetracation (English)
7 October 2016
2 references
kanamycin C tetracation (English)
7 October 2016
1 reference
(1R,2S,3S,4R,6S)-4,6-Diammonio-3-[(3-ammonio-3-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 2-ammonio-2-deoxy-alpha-D-glucopyranoside (English)
7 October 2016
2 references
kanamycin C tetracation (English)
7 October 2016
2 references